NMPA Approval

Cefoperazone Sodium and Sulbactam Sodium for Injection

Approval Number

国药准字H20023306

Registration Date

April 9, 2024

Previous Approval Numbers

国药准字H20023306

Drug Information

Generic Name

注射用头孢哌酮钠舒巴坦钠

Trade Name

海舒必

Dosage Form

注射剂

Strength

0.5g（C₂₅H₂₇N₉O₈S₂ 0.25g与C₈H₁₁NO₅S 0.25g）

Drug Type

化学药品

Registration Date

April 9, 2024

Company Address

珠海市金湾区创业北路38号

Company Address

珠海市金湾区创业北路38号

Empowering clinical research with data-driven insights and AI-powered tools.

注射用头孢哌酮钠舒巴坦钠 - NMPA 批准文号 | MedPath